Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Get Free Report) saw a large increase in short interest in August. As of August 14th, there was short interest totaling 44,970 shares, an increase of 61.3% from the July 30th total of 27,888 shares. Based on an average daily trading volume, of 41,985 shares, the short-interest ratio is currently 1.1 days. Currently, 0.4% of the shares of the stock are sold short.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Ruggaard & Associates LLC lifted its holdings in Columbia Research Enhanced Value ETF by 0.6% in the 1st quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock valued at $1,500,000 after purchasing an additional 322 shares in the last quarter. Western Wealth Management LLC acquired a new position in shares of Columbia Research Enhanced Value ETF during the 1st quarter worth approximately $29,000. Cetera Investment Advisers purchased a new stake in Columbia Research Enhanced Value ETF in the 1st quarter valued at $300,000. First Interstate Bank purchased a new stake in shares of Columbia Research Enhanced Value ETF in the first quarter valued at about $1,321,000. Finally, World Investment Advisors grew its stake in shares of Columbia Research Enhanced Value ETF by 12.8% in the 1st quarter. World Investment Advisors now owns 46,609 shares of the company’s stock valued at $1,334,000 after buying an additional 5,283 shares during the period.
Columbia Research Enhanced Value ETF Stock Down 0.2%
Shares of NYSEARCA REVS traded down $0.07 during midday trading on Tuesday, hitting $33.81. The stock had a trading volume of 26,889 shares, compared to its average volume of 51,451. The company has a market capitalization of $338.10 million, a PE ratio of 16.41 and a beta of 0.79. The stock has a 50 day simple moving average of $33.05 and a 200-day simple moving average of $31.14. Columbia Research Enhanced Value ETF has a 1 year low of $27.24 and a 1 year high of $34.23.
About Columbia Research Enhanced Value ETF
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Further Reading
- Five stocks we like better than Columbia Research Enhanced Value ETF
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
